Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
Northstrive Biosciences has submitted a pre-Investigational New Drug, or pre-IND, meeting request to the FDA for EL-22, a novel myostatin asset ...
Russia has freed an American citizen detained on drug charges, in what the State Department called a “welcome gesture” ahead ...
The drug has already garnered rare pediatric disease ... As the company prepares for its regulatory meetings, the healthcare community and investors are watching closely for the potential impact ...
OS Therapies signed agreements for the commercial manufacture of OST-HER2 as it prepares for an FDA meeting and potential BLA submission. Phase 2b data show OST-HER2 significantly improved 12 ...
Following the FDA meeting, the Company anticipates that it will be submitting a Biologics Licensing Authorization (BLA) application to the FDA for accelerated or conditional approval consideration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results